Maxcyte MXCT Balance Sheet (2020-2026)

NASDAQ MXCT
$1.18 +0.02 (+1.72%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Maxcyte Quarterly Balance Sheet

Periods 25 quarters
Latest Jun 2026

Maxcyte reported total assets of $184.67M and total liabilities of $25.92M for the quarter ended Jun 2026, down 16.0% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
3.96M4.37M4.85M5.12M5.61M6.28M7.22M8.21M9.28M10.29M11.39M11.89M12.62M13.59M15.62M16.52M16.98M17.26M18.27M17.40M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
58.97M47.78M239.78M109.17M43.02M11.06M37.83M54.56M49.17M46.51M22.25M37.51M36.96M27.88M23.39M15.22M12.97M20.07M14.56M15.04M
Receivables - NetNet Receivables
5.96M6.88M8.63M7.43M7.43M11.18M8.29M7.61M8.17M5.78M5.99M4.58M4.56M4.68M5.53M5.75M8.31M3.50M4.25M3.92M
Receivables
5.96M6.88M8.63M7.43M7.43M11.18M8.29M7.61M8.17M5.78M5.99M4.58M4.56M4.68M5.53M5.75M8.31M3.50M4.25M3.92M
Raw Materials
1.62M2.68M3.62M4.65M5.24M5.65M6.04M5.72M5.92M5.69M5.63M5.41M5.56M4.72M4.47M4.12M3.86M3.86M3.49M3.60M
Work In Process
0.67M1.00M0.69M0.56M0.30M0.10M0.30M0.27M0.20M0.34M0.40M0.50M0.64M0.57M
Finished Goods
2.53M2.52M2.96M3.07M2.67M2.93M3.55M4.29M5.92M5.98M6.03M5.65M4.53M3.93M3.61M3.48M3.35M3.18M3.50M3.63M
Inventory
4.15M5.20M6.58M7.72M7.91M8.58M10.26M11.02M12.53M12.23M11.96M11.16M10.39M8.91M8.27M7.93M7.61M7.55M7.63M7.80M
Prepaid Assets
3.31M2.19M1.31M3.28M3.26M2.23M1.88M3.40M3.90M3.21M2.58M4.12M3.61M3.68M2.97M3.00M4.28M4.21M3.66M
Current Assets
269.54M270.43M265.79M257.83M252.28M252.27M246.44M236.62M214.34M190.19M178.67M175.65M172.91M171.68M155.75M143.22M124.64M118.37M122.94M121.27M
Non-Current Assets
Property, Plant & Equipment (Net)
6.81M7.68M13.20M20.60M22.99M23.73M24.95M24.32M23.77M23.51M22.80M21.72M20.97M19.71M19.92M19.40M18.62M17.53M16.64M14.90M
Long-Term Investments
18.43M42.94M45.03M42.48M42.80M35.78M36.42M38.60M52.27M52.57M40.81M36.23M
Goodwill
3.92M3.75M3.55M
Intangibles
0.65M0.64M0.67M0.65M0.78M0.77M
Goodwill & Intangibles
4.57M4.39M4.22M0.65M0.78M0.77M
Other Non-Current Assets
0.32M0.32M1.05M0.92M1.19M0.81M0.40M0.60M0.62M0.39M0.29M0.64M1.05M1.53M1.91M2.80M2.58M2.47M2.61M1.03M
Non-Current Assets
8.15M13.69M25.16M31.95M34.13M34.39M35.10M34.59M52.39M78.08M79.26M75.85M75.70M67.79M74.21M76.53M88.83M84.14M71.54M63.40M
Assets
277.69M284.12M290.96M289.78M286.41M286.65M281.54M271.20M266.73M268.27M257.93M251.50M248.61M239.47M229.96M219.75M213.48M202.51M194.47M184.67M
Liabilities
Current Liabilities
Accounts Payables
0.72M1.82M4.37M2.46M2.09M0.29M3.50M1.60M0.45M0.74M1.67M0.95M1.86M1.36M2.28M1.21M1.29M1.40M1.20M1.73M
Payables
0.72M1.82M4.37M2.46M2.09M0.29M3.50M1.60M0.45M0.74M1.67M0.95M1.86M1.36M2.28M1.21M1.29M1.40M1.20M1.73M
Accumulated Expenses
4.96M6.52M3.87M7.90M8.23M8.27M6.91M6.41M9.92M11.27M6.50M7.08M8.20M8.30M5.03M6.40M8.31M7.81M4.37M4.17M
Current Deferred Revenue
6.33M6.75M6.83M7.31M6.29M6.71M5.75M4.69M5.59M5.07M4.48M3.37M6.65M5.25M4.14M2.64M5.20M3.60M3.27M2.46M
Total Current Liabilities
12.58M15.62M15.55M18.11M16.76M15.43M16.64M13.20M16.65M17.86M13.48M12.28M17.62M15.78M12.73M11.55M16.10M14.27M10.21M9.89M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue
0.45M0.34M
Operating Leases
0.50M5.15M12.77M14.05M14.87M15.94M15.78M15.71M15.38M17.97M17.82M17.65M17.41M17.17M17.55M17.20M16.85M16.49M16.11M15.72M
Other Non-Current Liabilities
0.50M0.45M0.45M0.39M1.32M1.31M1.31M1.32M0.28M0.28M0.31M0.28M0.27M0.27M0.25M0.23M0.26M0.26M0.30M
Total Non-Current Liabilities
13.08M20.77M28.32M32.16M31.36M32.42M28.91M32.03M35.82M31.29M29.93M35.03M32.95M30.28M28.78M32.97M30.75M26.32M25.62M
Total Liabilities
13.57M21.22M28.77M32.55M31.98M32.69M33.73M30.22M33.35M36.11M31.57M30.23M35.31M33.22M30.55M29.03M33.20M31.02M26.59M25.92M
Shareholder's Equity
Total Debt
Common Equity
264.12M262.90M262.18M257.22M254.43M253.97M247.82M240.98M233.38M232.17M226.36M221.26M213.30M206.25M199.41M190.72M180.28M171.49M167.89M158.75M
Liabilities and Shareholders Equity
277.69M284.12M290.96M289.78M286.41M286.65M281.54M271.20M266.73M268.27M257.93M251.50M248.61M239.47M229.96M219.75M213.48M202.51M194.47M184.67M
Treasury Shares
1.31M
Retained Earnings
-109.43M-114.30M-118.37M-126.63M-133.07M-137.88M-148.76M-159.27M-170.52M-175.80M-185.32M-194.70M-206.26M-216.85M-227.11M-239.47M-251.89M-261.48M-266.23M-275.11M

Maxcyte Balance Sheet API

Pull Maxcyte's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MXCT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY